title: Special concerns in defining, studying, and treating dystonia in children.
abstract: Dystonia is movement disorder with many diverse underlying etiologies. Some of those etiologies manifest at specific stages of development or at specific ages. Others may present early in life and evolve as the individual develops. The appearance of symptoms during a time of nervous system development poses special challenges to the neurologist. Normal functions change appearance, dysfunction may manifest in an age-dependent manner, and age-dependent differences in beneficial and toxic effects of treatments all introduce complexities to the process of diagnosis, functional assessment, and therapeutics. Consideration of these developmental differences is essential in assuring a universal definition of dystonia, and for developing valid and reliable assessment tools that can be compared across the lifespan, and more effective therapeutics. © 2013 Movement Disorder Society.
authors.affiliation: Departments of Neurology, Neurobiology & Anatomy, Brain & Cognitive Sciences, and Pediatrics, Division of Child Neurology, University of Rochester, Rochester, New York, USA.
authors.forename: Jonathan W
authors.initials: JW
authors.lastname: Mink
mesh_terms: D000818:Animals; D002648:Child; D004421:Dystonia / Q000175:diagnosis* / Q000628:therapy*; D006801:Humans; D010372:Pediatrics; D012737:Sex Factors
keywords: development; pediatrics; rating scales; treatment
references.citation: Pediatr Neurol. 2002 May;26(5):365-8
references.pmid: 12057796
references.citation: Pediatrics. 2002 Oct;110(4):e46
references.pmid: 12359819
references.citation: Pediatr Neurol. 2008 Oct;39(4):259-65
references.pmid: 18805364
references.citation: Neuropediatrics. 1991 Nov;22(4):220-4
references.pmid: 1775219
references.citation: Dev Med Child Neurol. 2010 May;52(5):e83-7
references.pmid: 20540176
references.citation: Pediatr Neurol. 2009 Apr;40(4):258-64
references.pmid: 19302937
references.citation: Neurosurgery. 2011 Mar;68(3):738-43; discussion 743
references.pmid: 21164379
references.citation: Mov Disord. 2010 Aug 15;25(11):1538-49
references.pmid: 20589866
references.citation: J Pediatr Orthop. 1996 Jul-Aug;16(4):500-4
references.pmid: 8784706
references.citation: Psychopharmacol Bull. 1977 Apr;13(2):39-41
references.pmid: 859991
references.citation: Mov Disord. 2013 Jun 15;28(7):863-73
references.pmid: 23649720
references.citation: Pediatrics. 2003 Jan;111(1):e89-97
references.pmid: 12509602
references.citation: Pediatr Neurol. 2006 Dec;35(6):375-81
references.pmid: 17138005
references.citation: Brain Dev. 2005 Apr;27(3):185-8
references.pmid: 15737699
references.citation: J Child Neurol. 2007 May;22(5):530-7
references.pmid: 17690057
references.citation: Dev Med Child Neurol. 1999 Jun;41(6):404-11
references.pmid: 10400175
references.citation: Neurology. 2006 Sep 26;67(6):1083-5
references.pmid: 17000985
references.citation: Eur J Paediatr Neurol. 2012 Sep;16(5):501-8
references.pmid: 22258088
references.citation: Pediatrics. 2005 Dec;116(6):1427-32
references.pmid: 16322167
references.citation: Neurology. 1985 Jan;35(1):73-7
references.pmid: 3966004
references.citation: Pediatrics. 2006 Nov;118(5):2159-67
references.pmid: 17079590
references.citation: Eur J Paediatr Neurol. 2013 Jul;17(4):353-60
references.pmid: 23332134
references.citation: Mov Disord. 2003 Mar;18(3):303-12
references.pmid: 12621634
references.citation: Neurology. 1986 Feb;36(2):160-4
references.pmid: 3511401